GrowBLOX Sciences, Inc. has been garnering the attention of the investment community.
July 21 2014 - 9:41AM
InvestorsHub NewsWire
With four separate revenue drivers,
a unique first-of-its-kind technology, an individual proprietary
cannabis strains and a presence within a growing list of states,
GrowBLOX Sciences, Inc. has been garnering the attention of the
investment community over the last few months. Not only has
GBLX seen explosive highs nearly $3.50, but the recent pullback to
lows of $1 may have opened an opportunity for new investment.
After watching the trading from Friday’s afternoon session, a
deeper look at the company and the current industry climate are the
main reasons for wanting to keep an eye on this company heading
into the rest of the month.
The company's technology has been
built to set the standard for manufacturing and medical cannabis
producing technology, and has it positioned to become a key player
in the industry. Back in May, GBLX identified one of its
major revenue drivers would be partnering with in-state growers to
help them cultivate cannabis that meets patients' needs. To this
point, the company has entered into several key markets:
Nevada
GBLX became one of the "chosen 18" that were granted
special use permit licenses for medical marijuana dispensaries
through its local partnership, GBS NEVADA, LLC. The Company's
Fort Apache location is the only dispensary to service the needs of
patients in that area, giving GBLX a major advantage in the Nevada
market.
Florida
Mid July marked GBLX’s entry into
the Florida market through its wholly owned subsidiary, GB Sciences
Florida, LLC. The National Cannabis Industry Association
estimates medical marijuana will be a $785 million industry in
Florida with multiple economic opportunities. Governor Rick Scott
signed a law on June 16 allowing for
the limited use of a special strain of marijuana called
“Charlotte’s Web” to treat those suffering from epilepsy, cancer
and amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s
disease and this is just the first step for the state.
Florida will have the opportunity to enact a comprehensive,
workable medical marijuana law this November by voting yes
on Amendment Two.
Illinois
GrowBLOX is currently involved in
the application process for licensing in Illinois. As far as
timing goes, GBLX has acted quickly in preparation of the potential
move as state lawmakers have set final rules to allow medical
marijuana in Illinois. Door would be open for patients to
apply for ID cards this fall and to start purchasing legal cannabis
by next spring. The state intends to approve a total of 21 licenses
for cultivation and 60 for dispensaries by September.
According to the Marijuana Business Factbook, the IL market hosts
some 10,000 patients and will generate anywhere from $25 million to
$45 million in cannabis sales.
Puerto
Rico
The Company opened its subsidiary GB
Sciences Puerto Rico, Inc. and is monitoring the island's pending
legislation to legalize medical marijuana. The Puerto Rican
Senate is currently discussing the legalization of marijuana for
medical use and its cultivation and so far SB 517 has passed senate
in a 14-12 vote now moving on to the House; it would decriminalize
up to 14 grams of marijuana. As far as legalization of
medical, Representative Carlos Vargas introduced House Bill 1362 to
legalize medical marijuana and regulate its sale, possession and
consumption. During the public hearings on House Bill 1362, most
groups testified in favor of medical marijuana and argued similar
cases as other states moving forward with a motion to legalize the
medical use of the drug identifying that reform is needed to tackle
drug addiction and high incarceration rates.
With GBLX already set up in Nevada
and already establishing a presence in 3 more areas positioned for
some type of legalization, the company has significantly entrenched
itself as a driving force within the industry as a whole. Beyond
the cultivation aspect, the company has also put into place, key
relationships with banking and inside investment. Lazarus
Investment Partners LLLP, has acquired an additional 269,632 shares
in the open market for an additional $322,000 investment. Lazarus,
which already holds a 3,000,000-share investment, which actually
averaged UP their position in GrowBLOX. I’m sure it’s not
hard to see that by averaging up, the firm believes that this is an
undervalued investment under the $1.20 mark.
Furthermore, and quite possibly even
more important is a two-fold chain of events: 1. GBLX secured a
letter of intent with First Security Bank of Nevada for the purpose
of managing the currency and banking flow of The Company's
operating facilities and 2. The House voted Wednesday (7/16) in
a 236-186 win in support of making it easier for banks to do
business with legal pot shops and providers of medical marijuana.
This was a decision that rejected a move by Rep. John Fleming,
R-La., to block the Treasury Department from implementing guidance
it issued in February telling banks how to report on their dealings
with marijuana-related businesses without running afoul of federal
money-laundering laws. The Treasury guidance was intended to give
banks confidence that they can deal with marijuana businesses in
states where they're legal. For marijuana cultivation companies
like GrowBLOX in connection with its LOI puts GBLX in place to
immediately benefit from the previously signed LOI moving forward
with full access to banking operations as it stands
today.
There’s no doubt that the US is
moving toward a new industry explosion. Sentiment from the
quickly growing millennial generation is in clear support for full
legalization. Americans age 18 to 29 oppose the federal
prohibition of marijuana, according to national polling data compiled by the Reason
Foundation. In addition to this, of those polled, only 14 percent
said that someone who consumes marijuana should go to jail.
So as more states continue to move toward some form of legalization
not only has GBLX positioned itself ahead of these motions through
subsidiaries and partnerships, but it has also been incredibly
active in providing the necessary quality that many medical
programs are looking for.
Although GBLX has gone through a
consolidation over the past week, it looks like interest has built
once again following announcements from Capitol Hill in addition to
the companies continued growth in additional markets like Illinois
and Florida so heading into the week ahead, this is going to be a
stock that I will be watching very closely especially after the
late afternoon activity from Friday.
GB Sciences (PK) (USOTC:GBLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
GB Sciences (PK) (USOTC:GBLX)
Historical Stock Chart
From Apr 2023 to Apr 2024